Improved therapeutic effectiveness by combining liposomal honokiol with cisplatin in lung cancer model

BMC Cancer

Volumn 8, Issue , 2008, Pages

  Jiang, Qi Qi ^a,b   Fan, Lin Yu ^a   Yang, Guang Li ^a   Guo, Wen Hao ^a   Hou, Wen Li ^a   Chen, Li Juan ^a   Wei, Yu Quan ^a  

^a SICHUAN UNIVERSITY   (China)

^b CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CD31 ANTIGEN; CISPLATIN; HONOKIOL; LIPOSOME; ANTINEOPLASTIC AGENT; BIPHENYL DERIVATIVE; LIGNAN; PLANT EXTRACT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIANGIOGENIC ACTIVITY; ANTIBODY LABELING; ANTIGEN ANTIBODY REACTION; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CANCER MODEL; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG POTENTIATION; DRUG TISSUE LEVEL; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; LIVER TOXICITY; LUNG CANCER; LUNG TOXICITY; MONOTHERAPY; MOUSE; NEPHROTOXICITY; NICK END LABELING; NONHUMAN; NUDE MOUSE; TISSUE SECTION; TUMOR XENOGRAFT; WEIGHT REDUCTION; ANIMAL; BIOSYNTHESIS; CANCER TRANSPLANTATION; CHEMISTRY; LUNG TUMOR; METABOLISM; NEOVASCULARIZATION (PATHOLOGY); TUMOR CELL LINE;

ANIMALS; ANTIGENS, CD31; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; APOPTOSIS; BIPHENYL COMPOUNDS; CELL LINE, TUMOR; CISPLATIN; HUMANS; IN SITU NICK-END LABELING; LIGNANS; LIPOSOMES; LUNG NEOPLASMS; MICE; NEOPLASM TRANSPLANTATION; NEOVASCULARIZATION, PATHOLOGIC; PLANT EXTRACTS;

EID: 52449102499     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-8-242     Document Type: Article

References (31)

1. Khuri FR Herbst RS Fossella FV Emerging therapies in non-small-cell lung cancer Ann Oncol 2001, 12:739-44. 10.1023/A:1011197500223 11484947
2. Soria J-C Jiang SJ Khuri FR Hassan K Liu D Hong WK Mao L Overexpression of cyclin B1 in early-stage non-small cell lung cancer and its clinical implication Cancer Res 2000, 60:4000-4. 10945597
3. Vora SA Daly BDT Blaszkowsky L McGrath JJ Bankoff M Supran S Dipetrillo TA High dose radiation therapy and chemotherapy as induction treatment for stage III nonsmall cell lung carcinoma Cancer 2000, 89:1946-52. 10.1002/1097-0142(20001101)89:9<1946::AID-CNCR10>3.0.CO;2-1 11064351
4. Bai X Cerimele F Ushio-Fukai M Waqas M Campbell PM Govindarajan B Der CJ Battle T Frank DA Ye K Murad E Dubiel W Soff G Arbiser JkL Honokiol, a small molecular weight natural product, inhibits angiogenesis in vitro and tumor growth in vivo J Biol Chem 2003, 278:35501-7. 10.1074/ jbc.M302967200 12816951
5. Hirano T Gotoh M Oka K Natural flavonoids and lignans are potent cytostatic agents against human leukemic HL-60 cells Life Sci 1994, 55:1061-1069. 10.1016/0024-3205(94)00641-5 8084211
6. Wang T Chen F Chen Z Wu YF Xu XL Zheng S Hu X Honokiol induces apoptosis through p53-independent pathway in human colorectal cell line RKO World J Gastroenterol 2004, 10:2205-2208. 15259066
7. Hibasami H Achiwa Y Katsuzaki H Imai K Yoshioka K Nakanishi K Ishii Y Hasegawa M Komiya T Honokiol induces apoptosis in human lymphoid leukemia Molt 4B cells Int J Mol Med 1998, 2:671-673. 9850734
8. Ishitsuka K Hideshima T Hamasaki M Raje N Kumar S Hideshima H Shiraishi N Yasui H Roccaro AM Richardson P Podar K Gouill SL Chauhan D Tamura K Arbiser J Anderson KC Honokiol overcomes conventional drug resistance in human multiple myeloma by induction of caspase-dependent and independent apoptosis Blood 2005, 106:1794-800. 1895215 15870175 10.1182/ blood-2005-01-0346
9. Yang SE Hsieh MT Tsai TH Hsu SL Down-modulation of Bcl-XL, release of cytochrome c and sequential activation of caspases during honokiol-induced apoptosis in human squamous lung cancer CH27 cells Biochem Pharmacol 2002, 63:1641-1651. 10.1016/S0006-2952(02)00894-8 12007567
10. Konoshima T Kozuka M Tokuda H Nishino H Iwashima A Haruna M Ito K Tanabe M Studies on inhibitors of skin tumor promotion, IX: Neolignans from Magnolia officinalis J Nat Prod 1991, 54:816-822. 10.1021/np50075a010 1659613
11. The International Adjuvant Lung Cancer Trial Collaborative Group Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer N Engl J Med 2004, 350:351-60. 10.1056/NEJMoa031644 14736927
12. Folkman J Seminars in medicine of the Beth Israel Hospital, Boston. Clinical applications of research on angiogenesis N Engl J Med 1995, 333:1757-63. 10.1056/NEJM199512283332608 7491141
13. Li G Tian L Hou JM Ding ZY He QM Feng P Jun WY Xiao F Yao B Zhang R Peng F Jiang Y Luo F Zhao X Zhang L Zhou Q Wei YQ Improved therapeutic effectiveness by combining recombinant CXC chemokine ligand 10 with Cisplatin in solid tumors Clin Cancer Res 2005, 11:4217-24. 10.1158/ 1078-0432.CCR-04-2117 15930360
14. Wang X Wang Y Geng Y Li F Zheng C Isolation and purification of honokiol and magnolol from cortex Magnoliae officinalis by high-speed counter-current chromatography J Chromatogr A 2004, 1036:171-5. 10.1016/ j.chroma.2004.02.073 15146918
15. Yuan ZP Chen LJ Fan LY Tang MH Yang GL Yang HS Du XB Wang GQ Yao WX Zhao QM Bin Y Rui W Peng D Wei Z Wu HB Xia Z Wei YQ Liposomal quercetin efficiently suppresses growth of solid tumors in murine models Clin Cancer Res 2006, 12:3193-9. 10.1158/1078-0432.CCR-05-2365 16707620
16. Saris CP Vaart van de PJ Rietbroek RC Blommaert FA In vitro formation of DNA adducts by cisplatin, lobaplatin and oxaliplatin in calf thymus DNA in solution and in cultured human cells Carcinogenesis 1996, 17:2763-9. 10.1093/carcin/17.12.2763 9006117
17. Faivre S Chan D Salinas R Woynarowska B Woynarowski JM DNA strand breaks and apoptosis induced by oxaliplatin in cancer cells Biochem Pharmacol 2003, 66:225-37. 10.1016/S0006-2952(03)00260-0 12826265
18. Zhong X Li X Wang G Zhu Y Hu G Zhao J Neace C Ding H Reed E Li QQ Mechanisms underlying the synergistic effect of SU5416 and cisplatin on cytotoxicity in human ovarian tumor cells Int J Oncol 2004, 25:445-51. 15254743
19. Yoshikawa A Saura R Matsubara T Mizuno K A mechanism of cisplatin action: Antineoplastic effect through inhibition of neovascularization Kobe J Med Sci 43:109-120. 9489296
20. Ahn KS Sethi G Shishodia S Sung B Arbiser JL Aggarwal BB Honokiol potentiates apoptosis, suppresses osteoclastogenesis, and inhibits invasion through modulation of nuclear factor-kappaB activation pathway Mol Cancer Res 2006, 4:621-33. 10.1158/1541-7786.MCR-06-0076 16966432
21. Shigemura K Arbiser JL Sun SY Zayzafoon M Johnstone PA Fujisawa M Gotoh A Weksler B Zhau HE Chung LW Honokiol, a natural plant product, inhibits the bone metastatic growth of human prostate cancer cells Cancer 2007, 109:1279-89. 10.1002/cncr.22551 17326044
22. Battle TE Arbiser J Frank DA The natural product honokiol induces caspase-dependent apoptosis in B-cell chronic lymphocytic leukemia (B-CLL) cells Blood 2005, 106:690-697. 10.1182/blood-2004-11-4273 15802533
23. Klement G Baruchel S Rak J Man S Clark K Hicklin DJ Continuous low-dose therapy with vinblastine and VEGF receptor-2 antibody induces sustained tumor regression without overt toxicity J Clin Invest 2000, 105:15-24. 382592 10619856 10.1172/JCI8829
24. Williams JI Weitman S Gonzalez CM Jundt CH Marty J Stringer SD Holroyd KJ Mclane MP Qiming C Zasloff M Von HD Squalamine treatment of human tumors in nu/nu mice enhances platinum-based chemotherapies Clin Cancer Res 2001, 7:724-33. 11297269
25. Aoyama Y Avruch J Zhang XF Nore1 inhibits tumor cell growth independent of Ras or the MST1/2 kinases Oncogene 2004, 23:3426-33. 10.1038/ sj.onc.1207486 15007383
26. Viloria-Petit AM Kerbel RS Acquired resistance to EGFR inhibitors: mechanisms and prevention strategies Int J Radiat Oncol Biol Phys 2004, 58(3):914-926. 14967451
27. Muther RS Bennett WM Ejects of dimethyl sulfoxide on renal function in man JAMA 1980, 244:2081-3. 10.1001/jama.244.18.2081 7001051
28. Marshall LF Camp PE Bowers SA Dimethyl sulfoxide for the treatment of intracranial hypertension: A preliminary trial Neurosurgery 1984, 14:659-63. 10.1097/00006123-198406000-00002 6462399
29. Rijtema M Mosig D Drukker A Guignard JP The effects of dimethyl sulfoxide on renal function of the newborn rabbit Biol Neonate 1999, 76:355-61. 10.1159/000014179 10567764
30. Allen TM Cullis PR Drug delivery systems: Entering the mainstream Science 2004, 19:1818-22. 10.1126/science.1095833
31. Batist G Ramakrishnan G Rao CS Chandrasekharan A Gutheil J Guthrie T Shah P Khojasteh A Nair MK Hoelzer K Tkaczuk K Park Lee LW Reduced cardiotoxicity and preserved antitumor efficacy of liposome-encapsulated doxorubicin and cyclophosphamide compared with conventional doxorubicin and cyclophosphamide in a randomized, multicenter trial of metastatic breast cancer J Clin Oncol 2001. 19:1444-54. 11230490